Linkerbot

1.1 Identity, headquarters, and business model

Linkerbot is a Beijing-based robotics-hardware company, headquartered in the Haidian District, that designs and mass-produces high-degree-of-freedom (DoF) dexterous robotic hands for humanoid robots, industrial automation, and research use. Public reporting places the company's founding in 2023, a timeline consistent with a May 2026 Reuters-sourced description of Linkerbot as a 'two-year-old unicorn.' The core product is the Linker Hand series, which spans roughly 6 to 42 degrees of freedom across direct-drive, linkage, and tendon-driven actuation architectures, supplemented by a 'Linker Craftsman' workstation shown at CES 2026. The company's own sitemap lists at least thirteen distinct product pages (models L6, L10, L20, L20G, L30, L30Z, O6, O7, D, J, R, W, and YCB), indicating a broad, tiered product line rather than a single flagship SKU. Linkerbot's business model is hardware-first: it manufactures and sells dexterous end effectors to humanoid-robot integrators, industrial buyers, and research institutions, and layers a software/data ecosystem (LinkerSkillNet, Open TeleDex) on top rather than building or selling complete robots itself. As of May 2026 the company's stage is best described as a large, private, venture-backed hardware unicorn that has just closed a 'Series B+' round; it is not publicly listed and has disclosed no IPO timetable.[CO001, CO002, CO003, CO004, CO005, CO006]

1.2 Leadership, governance, and key-person dependence

The public leadership picture for Linkerbot is thin and, in one respect, unresolved. May 2026 Reuters-sourced wire coverage (redistributed by BusinessWorld, the Straits Times, Yahoo Finance, and The Standard) names 'CEO Alex Zhou' as the executive who discusses production scale-up and the company's next fundraising target. Earlier, Chinese-language coverage from China Biz Insider dated November 2025 instead names 'Founder and CTO Zhou Yong' as the person quoted on order volume during the Series A+ financing era. No source reviewed for this chapter explicitly states whether Alex Zhou and Zhou Yong are the same individual under different English/Chinese name renderings, or whether a real title change from CTO to CEO occurred between the two reporting windows; this is recorded as an open, unresolved question rather than assumed either way. Beyond this single named executive (or pair of possibly-identical executives), no reviewed source discloses an independent board, outside directors, a founder equity split, or a succession plan. Because every piece of reviewed coverage — product strategy, fundraising commentary, and manufacturing scale-up plans — routes through one named spokesperson, key-person dependence risk is material for a company operating at a multi-billion-dollar valuation.[CO008, CO009, CO010, CO011, CO012]

1.3 Funding history, valuation, and investors

Linkerbot's disclosed financing history spans at least two distinct eras. In the Series A+ era, China Biz Insider reported in November 2025 that the company had just closed its fourth capital injection in eight months, with investors including Zhejiang Innovation Investment, CDH Investments' Baifu fund, Leju Robotics, and listed strategic investors Dongfang Precision and Aux, alongside earlier backers Ant Group and Sequoia China Seed Fund; round size was not disclosed. By late April/early May 2026, Linkerbot announced a 'Series B+' round that valued the company at approximately US$3 billion, with participation from Ant Group, Sequoia spin-off HongShan Group, the state-backed Zhongguancun Science Park Fund, Bank of China Asset Management, and Fosun Capital. In the same announcement, the company said it would seek a roughly US$6 billion valuation — double the Series B+ level — in its next financing round, without disclosing timing or whether that round would be a private financing or a public listing. No reviewed source discloses Linkerbot's total lifetime capital raised as of the report date; the only cumulative figure available is $150 million raised since April 2025, disclosed in a December 2025 press release alongside a shipment milestone, which necessarily predates and understates the capital implied by the $3 billion Series B+ valuation. No secondary sales or debt/credit facilities were disclosed in any reviewed source. It is also worth noting that the $3B/$6B valuation figures are corroborated across BusinessWorld, the Straits Times, Yahoo Finance, and The Standard, but all four appear to trace to the same underlying Reuters wire story plus the company's own statement, so the corroboration is broad in distribution but narrow in original reporting chains.[CO013, CO014, CO015, CO016, CO017, CO018]

1.4 Cover metrics: scale, market share, customers, and disclosure gaps

Linkerbot's most heavily cited cover metric is its claimed global market share in high-degree-of-freedom robotic hands: the company states it holds over 80% share and is the only manufacturer mass-producing more than 1,000 high-DoF hands per month, a claim repeated in both company press releases and Reuters-sourced coverage. An independent industry tracker (TechBuzz China) and a Chinese-language market analysis (Gongboshi Robot) both describe Linkerbot as the category leader with 80%+ share as of early-to-mid 2026, providing partial third-party corroboration beyond the company's own statements, though neither source discloses its underlying methodology. On production scale, Linkerbot said in May 2026 that it was scaling monthly output from almost 5,000 units to a planned 10,000 units 'soon,' building on a disclosed cumulative milestone of more than 10,000 hands shipped by December 2025 and a highest single month above 4,000 units. Disclosed named customers are limited to Samsung Electronics and Siemens for industrial/production use, plus research use described as including Stanford and MIT, though no source provided contract values, unit counts by customer, or renewal information. Revenue, ARR, gross margin, and headcount remain fully undisclosed in every source reviewed for this chapter, and Linkerbot's HKTDC international-sourcing storefront page returned a page-not-found result, a minor but concrete channel-visibility gap. Separately, China's National Development and Reform Commission publicly flagged in 2026 that more than 150 humanoid-robot companies now operate in China and warned against excessive product duplication and speculative bubbles — a sector-level adverse signal relevant to how aggressively any single company's valuation trajectory should be read.[CO020, CO021, CO022, CO023, CO024, CO025]

1.5 Exhibits

2.1 Market boundary, adjacencies, and status-quo substitutes

The market Linkerbot actually competes in is narrower than 'humanoid robots' as a whole: it is the sub-segment of the embodied-AI hardware stack devoted to dexterous end-effectors — robotic hands and grippers with human-like degrees of freedom — plus an adjacent manipulation-software layer (LinkerSkillNet, Open TeleDex). Excluded from that addressable spend is the much larger bill of materials for a complete humanoid robot: chassis, locomotion, batteries, and general-purpose AI compute, all of which are supplied by other vendors or built in-house by robot integrators. Adjacent markets include full humanoid-robot makers such as Unitree and Tesla's Optimus program that currently build their own hands rather than buying from a supplier, and industrial-automation gripper incumbents that could add degrees of freedom over time and encroach on the low end of Linkerbot's category. The most direct status-quo substitute for a buyer that does not need full human-like dexterity is a simple 2-3 finger parallel-jaw gripper (as sold by incumbents like RightHand Robotics), or simply continuing to use human manual labor for fine-manipulation tasks that are not yet cost-effective to automate. Framing the market this way matters because whole-humanoid-robot TAM figures, however large, systematically overstate what Linkerbot itself can capture.[CM001, CM002, CM003, CM004]

2.2 TAM/SAM/SOM sizing across multiple, disagreeing lenses

No single trusted TAM number exists for this market. Whole-humanoid-robot market-size estimates for 2026 range from about $4.2 billion (Grand View Research) and $5.41 billion (MarketsandMarkets) to $10.69 billion (Future Market Insights) and $10.9 billion (Global Market Insights) — a spread of more than 2x for the same year, with none of the reviewed publisher pages fully disclosing their underlying methodology in the excerpts retrieved. Goldman Sachs Research instead frames the opportunity as a long-horizon scenario range: a base case near $38 billion by 2035, with a 'blue sky' scenario reaching $154 billion if reliability and cost barriers fall faster than expected. None of these whole-market figures isolate the dexterous-hand sub-segment Linkerbot actually sells into. The closest available proxy is a China Biz Insider estimate that the China-only dexterous-hand market alone will exceed $3.7 billion by 2031, alongside an industry tracker's observation that Chinese suppliers already provide 70-80% of global commercial high-DoF robot hands at unit prices that have fallen from over $100,000 to below $2,000. Even that narrower figure is a single-article citation rather than an audited market study, and no reviewed source provides a serviceable-obtainable-market (SOM) figure specific to Linkerbot; the company's own 80%+ share claim is applied against a category boundary ('global high-DoF dexterous hand market') that it defines itself rather than against any named third-party sizing study.[CM005, CM006, CM007, CM008, CM009, CM010]

2.3 Buyer, user, and payer segmentation and adoption path

Buyers of Linkerbot-style dexterous hands fall into at least three segments with different budget ownership. Industrial and electronics-manufacturing buyers — the segment that includes Linkerbot's own disclosed customers Samsung Electronics and Siemens — typically fund purchases from an automation/capex budget where the buyer, user, and payer are the same corporate function, and the adoption trigger is reliability and cost parity against an existing gripper or manual process. Humanoid-robot integrators such as Unitree represent a distinct 'buy vs. build' segment: they can either purchase hands from a supplier like Linkerbot or design their own, so the adoption trigger is a cost and time-to-market comparison rather than a simple procurement decision. Research institutions (Linkerbot states usage including Stanford and MIT) are funded through grants and lab budgets rather than enterprise procurement, so their adoption trigger is publication and demonstration value rather than commercial ROI, making them a low-revenue but high-visibility channel. A Morgan Stanley-referenced 2026 survey found that many Chinese enterprise buyers want humanoid/dexterous automation but do not yet consider available products reliable enough for full production deployment, suggesting the typical adoption funnel — awareness, pilot, certification, production integration, reorder — is still concentrated in its earlier stages across the sector, Linkerbot included, even though no source discloses Linkerbot-specific funnel conversion data.[CM012, CM013, CM014, CM015, CM016, CM031]

2.4 Growth drivers and adoption constraints

Several forces are pushing adoption forward. China's 15th Five-Year Plan (2026-2030) elevates AI-powered robotics to a core national strategic priority, a sustained policy tailwind for domestic hand makers. Per-unit hand pricing has fallen sharply — from over $100,000 to below $2,000 for comparable-generation Chinese-made hands, with some competitors publicly projecting sub-$100 pricing within a few years — which should expand the buyer pool well beyond well-capitalized robotics labs. Public demonstrations by rival humanoid-robot makers have also lifted sector-wide investor and buyer attention in 2026. Countervailing constraints are real and material. China's National Development and Reform Commission has publicly warned that more than 150 humanoid-robot companies now exist domestically and cautioned against product duplication and speculative bubbles — a signal that policy tightening or investor caution could follow. On the demand side, US lawmakers introduced the GUARD Act and the American Security Robotics Act in March 2026, both aimed at banning US federal government procurement and use of Chinese-made humanoid and ground robots, a direct constraint on any US public-sector demand for Chinese-made components including dexterous hands. Broader US semiconductor and advanced-computing export controls could further constrain the electronics inside high-end hands sold into or via US-linked supply chains. Finally, international safety standards (ISO 10218, ISO/TS 15066) and a still-early reliability profile — per the Morgan Stanley-referenced enterprise survey — mean many industrial buyers remain in pilot mode rather than committing to production-scale, multi-unit orders.[CM017, CM018, CM019, CM020, CM021, CM022]

2.5 Exhibits

3.1 Competitive landscape: peers, incumbents, adjacents, and substitutes

Linkerbot's competitive set spans three distinct categories. The first is direct dexterous-hand specialists that, like Linkerbot, sell hands as a standalone product: Inspire Robots (因时机器人), Shadow Robot (UK), and Zhaowei Mechatronics, a components manufacturer that has entered the category. The second, and arguably the more strategically important category, is full-stack humanoid-robot makers that design and manufacture their own hands rather than buying from an independent supplier — Unitree, AgiBot, Fourier Intelligence, UBTech, and Tesla all fall here, and each represents both a potential customer (if they ever chose to buy rather than build) and a permanent competitive threat (since they could sell excess hand capacity or spin out a hand business, as AgiBot has begun to do). The third category is non-China humanoid-robot makers — Figure AI, Apptronik, and 1X Technologies — that build their own hands in-house for now but represent the segment most exposed to future US policy actions that could reshape global sourcing patterns. Beyond dedicated dexterous hands, the status-quo substitute for any buyer that does not need full human-like dexterity is a simple parallel-jaw gripper (as sold by incumbents like RightHand Robotics), or simply continuing to rely on human manual labor. Lower-cost, lab-oriented adjacent products — Wonik Robotics' Allegro Hand and the open-source LEAP Hand — serve research buyers rather than industrial ones and are unlikely to directly displace Linkerbot's industrial customer base.[CP001, CP002, CP003, CP004, CP029, CP031]

3.2 Competitor profiles: scale, funding, and strategic direction

Unitree disclosed three tiers of self-developed dexterous hands in its March 2026 IPO prospectus — the 20-DoF Dex5-1, the 7-DoF Dex3-1, and the Dex1-1 gripper — and was valued at roughly $1.6 billion after a mid-2025 Series C round before later filing for an IPO reported at up to $580 million in proceeds as humanoid-robot sales began to surpass its legacy quadruped-robot business. AgiBot has begun selling its OmniHand series standalone, pricing a 10-DoF model at roughly $1,350, directly undercutting the historical practice of bundling hands only with complete robots. Shadow Robot remains the acknowledged technical benchmark at 24 DoF and 100+ sensors, but at more than $140,000 per hand its volume production has stalled — illustrating that raw technical leadership has not translated into scale. Zhaowei Mechatronics, entering from a components-manufacturing background, offers the DM17 (17 active DoF) and LM06 (150N grip) product lines. Among full-stack Western competitors, Figure AI leads on capital with a $39 billion post-money valuation after raising more than $1 billion in its Series C, ahead of Apptronik ($520 million raised at a $5 billion valuation) and the more modestly funded 1X Technologies ($100 million Series B). X Square Robot, a China-based embodied-AI competitor, surpassed a $2.8 billion valuation across four consecutive rounds but is explicitly targeting household/consumer manipulation tasks rather than Linkerbot's stated industrial/craftsmanship focus, reducing direct overlap. UBTech's Walker S2 humanoid began mass production with disclosed orders exceeding 800 million yuan, and Galbot (RMB 2.5 billion raised) and Robotera (over $200 million raised) show that fresh capital keeps entering the broader Chinese humanoid-robotics ecosystem that Linkerbot's hands ultimately serve or compete with.[CP005, CP006, CP007, CP008, CP009, CP010]

3.3 Pricing, GTM, and trust/regulatory comparisons

On disclosed pricing, Linkerbot's O6 model at roughly $920 undercuts AgiBot's standalone 10-DoF hand (~$1,350) and sits far below Shadow Robot's technical-benchmark hand (>$140,000) and generic overseas comparables cited at $150,000-$220,000 by an industry tracker. Unitree, Fourier Intelligence, and UBTech disclose no standalone hand pricing at all, because each bundles its hand exclusively into a complete humanoid-robot sale — meaning direct like-for-like price comparison is only possible against AgiBot and Shadow Robot among the named full-stack/technical-benchmark peers. On go-to-market, Linkerbot's disclosed channel is direct international press and trade-show visibility (CES 2026, PR Newswire distribution) combined with direct sales to named industrial and research accounts; no reviewed source discloses a formal reseller or distributor network, in contrast to full-stack makers that reach end customers through their own robot sales organizations. On trust and regulatory posture, no reviewed source discloses formal safety or quality certifications specific to any named competitor's dexterous-hand product — including Linkerbot's own — beyond the sector-wide existence of ISO industrial-robot safety standards discussed in the Market Analysis chapter, leaving certification status as an open diligence item across the entire competitive set rather than a Linkerbot-specific weakness.[CP017, CP018, CP019, CP020, CP030]

3.4 Switching cost, lock-in, distribution power, and moat durability

Once a robot integrator has engineered its control stack, mounting, wiring harness, and manipulation-skill data around one supplier's hand, switching cost is likely non-trivial — creating a real, if unquantified, form of lock-in for whichever supplier is designed into a given robot platform. Distribution power sits disproportionately with the full-stack humanoid-robot makers (Unitree, AgiBot, Figure AI, UBTech), because they control the end-customer relationship; an independent hand supplier like Linkerbot depends on being designed into someone else's robot or selling direct to research/industrial accounts, a structurally weaker distribution position than the integrators themselves hold. Linkerbot's own moat claim rests on production scale and cost leadership — 80%+ claimed share, sub-$1,000 pricing, and a 1,000+ units/month production floor — rather than a single technical breakthrough, since Shadow Robot already holds a higher raw-DoF technical benchmark at far higher cost. That scale-based moat faces two concrete threats: commoditization risk, illustrated by AgiBot's and Zhaowei's entry at similar or lower price points, and a credibility risk around self-reported scale claims generally, illustrated by Humanoids Daily's report of a public dispute between Unitree and AgiBot over global shipment-leadership claims. China's National Development and Reform Commission's 2026 warning that more than 150 humanoid-robot companies now exist domestically is a further sector-wide adverse signal that overcapacity or consolidation could compress margins and valuations across the entire competitive set, Linkerbot included. No reviewed source documents a specific competitive win or loss for Linkerbot against any named rival, so moat durability here is substantially inferred rather than directly evidenced.[CP021, CP022, CP023, CP024, CP025, CP026]

3.5 Exhibits

4.1 Revenue streams, pricing model, and recognition gaps

Linkerbot's only clearly disclosed revenue stream is hardware sales of its Linker Hand product family, a line spanning at least 13 SKUs from 6 to 42 degrees of freedom, sold directly to industrial buyers, humanoid-robot integrators, and research institutions. The company also markets a software/platform layer — the LinkerSkillNet manipulation-skill ecosystem and the Open TeleDex teleoperation system — but no reviewed source discloses whether these generate separate license, subscription, or data-access revenue distinct from hardware sales; this is recorded as an open question rather than assumed to be either a real revenue line or pure marketing. On pricing, an independent industry tracker attributes a list price of approximately ¥6,666 (about $920) to the O6 entry-tier model, the only specific unit price found anywhere in reviewed sources, and quotes a company co-founder predicting prices could fall below ¥500 (about $70) within three years — an aggressive forward cost target rather than a stated current price. No source discloses pricing for the higher-DoF flagship models (L20, L20G, L30, L30Z, O7, and others), so a full pricing ladder across the product line cannot currently be constructed, and with no revenue-mix disclosure, revenue-recognition treatment cannot be assessed.[CI001, CI002, CI003, CI004, CI005, CI036]

4.2 GTM motion, sales efficiency, and cost structure

Linkerbot's disclosed go-to-market motion is direct sales to named industrial and research accounts (Samsung, Siemens, and research use described as including Stanford and MIT) combined with international press and trade-show visibility, most notably its CES 2026 debut; no reviewed source discloses a formal reseller or distributor network, and no source discloses sales-cycle length, customer acquisition cost, or payback-period proxies. On cost structure, industry commentary attributes Linkerbot's low list pricing partly to proprietary componentry (PEEK engineering polymer, in-house micro-reducers) and manufacturing scale rather than disclosed labor, overhead, or logistics figures; no source discloses gross margin, bill-of-materials cost, working-capital position, or planned capital expenditure beyond a general statement that new financing funds 'production capacity' improvements. Peer coverage of comparable manufacturing-scale thresholds (for example, AgiBot's push past 10,000 units) frames how capital-intensive reaching Linkerbot's own stated 10,000-unit/month target is likely to be, even though no Linkerbot-specific capex figure is available.[CI006, CI007, CI008, CI009, CI010, CI011]

4.3 Public traction versus private-metric gaps

Linkerbot's public traction is entirely unit-and-production based: the company disclosed shipping its 10,000th cumulative dexterous hand by December 2025 and scaling monthly production from almost 5,000 toward a targeted 10,000 units by mid-2026, alongside a separate Chinese-language report that the company targeted delivering 50,000 to 100,000 units across all of 2026 — a target five to ten times its disclosed end-2025 cumulative shipment level. None of this activity is matched by any disclosed financial-statement-level metric: no source discloses revenue, ARR, gross merchandise value, active-customer count, or utilization data. CB Insights maintains an analyst-tracked company profile, indicating some independent financial-data-provider coverage exists, though the specific financial fields it carries were not visible in the reviewed excerpt. This leaves a structural gap between strongly corroborated operational/unit traction and a complete absence of financial traction evidence.[CI012, CI013, CI014, CI028]

4.4 Capital adequacy and financing dependency

Building on (but not restating) the historical round-by-round chronology recorded in the Company Overview chapter, this chapter's capital-adequacy-specific evidence shows Linkerbot closing a Series B round of roughly RMB 1.5 billion (about $210 million) around February 12, 2026, led by Daode Investment and Shengshi Investment with a long list of additional participants, with disclosed use of proceeds centered on core R&D, production-capacity expansion, and full-stack manipulation-platform capability. By early May 2026 the company had closed a further 'Series B+' round at approximately a $3 billion valuation with investors including Ant Group, HongShan Group, Zhongguancun Science Park Fund, Bank of China Asset Management, and Fosun Capital, and disclosed a roughly $6 billion target for its next round. Separately, listed company Dongfang Precision (002611.SZ) discloses holding an approximately 4.36% direct equity stake in Linkerbot, confirmed unchanged as of a June 2026 investor-relations response citing its 2025 annual report — a rare piece of financial-disclosure-grade evidence about Linkerbot's cap table, since it comes through a public company's own regulatory disclosure obligations rather than press coverage of the private company itself. No source reconciles the February 2026 Series B round size with the capital implied by the May 2026 Series B+ valuation, so the amount of dilution and capital efficiency between the two events cannot be fully decomposed. No source discloses cash on hand, monthly burn, runway, a specific next-round trigger milestone, or any debt/project-finance obligation; China's National Development and Reform Commission's 2026 warning about sector-wide overcapacity among more than 150 domestic humanoid-robot companies is a relevant adverse macro signal for how aggressively Linkerbot's rapid, repeated financing cadence should be read.[CI015, CI016, CI017, CI018, CI019, CI020]

4.5 Financial verdict: revenue quality, margin path, and diligence blockers

Taken together, the public record on Linkerbot combines strong, multiply-corroborated evidence of unit-shipment traction and financing-round activity with a near-total absence of revenue, margin, cost-structure, and balance-sheet disclosure — a pattern typical of a fast-scaling private hardware company but a material blocker to any independent financial valuation. Revenue quality cannot be assessed because no source breaks out revenue by stream, segment, or geography. The margin path is unclear because gross margin, BOM cost, and warranty/defect costs are all undisclosed, and the co-founder's stated multi-year path toward sub-$70 unit pricing could reflect either a credible manufacturing cost curve or a deliberately loss-leading growth strategy funded by continued equity financing — the public record cannot distinguish between the two. Capital intensity is high, illustrated by comparable peer manufacturing-scale-up coverage, and Linkerbot's own financing dependency (three or more equity rounds in under 18 months) is likely to persist until, or unless, hardware margins and/or an undisclosed software/data revenue layer mature enough to fund growth internally. The most concrete near-term diligence blockers are the absence of any audited financial statement (a bar that comparable peer Unitree has already cleared via its own IPO prospectus), the unreconciled gap between the February 2026 Series B round size and the May 2026 Series B+ valuation, and the complete absence of headcount, cash position, or burn-rate disclosure.[CI029, CI032, CI033, CI034, CI035]

4.6 Exhibits

5.1 Product definition, workflow, and module map

In customer workflow terms, Linkerbot's product is a dexterous robotic-hand end-effector that an integrator mounts on a robot arm or humanoid platform and controls through a ROS or ROS2 driver stack and a Python/C++ SDK, rather than a complete robot the customer buys outright. The documented integration workflow — installing the SDK on Ubuntu 22.04 with ROS Humble and Python 3.10+, configuring hand parameters via a setting.yaml file, and then driving the hand through ROS topics or the LinkerHandApi Python class — is directly observable in Linkerbot's own GitHub-hosted SDK repositories. The company's official sitemap lists at least 13 distinct product pages (L6, L10, L20, L20G, L30, L30Z, O6, O7, D, J, R, W, YCB), but the ROS2 SDK's own README documents hardware support for a different, only partially overlapping model list (O6, L6, L7, O7, L10, L20, G20, L21) — a naming and coverage mismatch that is recorded here as an explicit inconsistency rather than assumed away. Flagship specifications disclosed in company materials include the L30's approximately ±0.2mm repeatability for precision-assembly work and the O6's 370g weight paired with a 50kg grip payload, attributed to PEEK engineering polymer and in-house-developed micro-reducers.[CE001, CE002, CE003, CE004, CE005, CE006]

5.2 Architecture and operating model

Linkerbot's hands cover three distinct actuation architectures — direct-drive, linkage, and tendon-driven — within a single product family, which an independent industry tracker highlights as unusually broad technology-route coverage compared to most single-architecture rivals. The industrial-tier L20 is described in company materials as using a proprietary 'Super Electric Cylinder' delivering 90% drive efficiency, 200N screw-end thrust, and a tested lifespan exceeding one million cycles, while a multi-modal 'sensing skin' tactile layer is marketed across the hand family. Above the hardware layer sits an open-source ROS/ROS2 SDK, URDF models, and a simulator (linker-sim) hosted on GitHub under the linker-bot organization — genuinely observable developer tooling rather than a marketing claim. By contrast, no GitHub repository or technical documentation was found by name for 'Open TeleDex' or 'LinkerSkillNet,' the two higher-level platform names the company markets most prominently; the closest matching repository is a general teleoperation-arm utility, suggesting these product names may sit over more narrowly named underlying code, or are simply not yet open-sourced. No single company-published diagram ties hardware, firmware, the open SDK layer, and these two proprietary platform layers together, so the architecture in this chapter is necessarily assembled from separate disclosures.[CE007, CE008, CE009, CE010, CE027, CE028]

5.3 Deployment, integration, reliability, and roadmap

On deployment and integration, Linkerbot provides real, inspectable tooling: multiple SDK language/framework variants (Python, C++, ROS1, ROS2), a URDF model repository compatible with standard simulation and motion-planning tools, and a dedicated simulator, all supporting Ubuntu 22.04 and ROS Humble as of the report date. Disclosed named customers/users span industrial production (Samsung, Siemens per company statements) and research institutions (Stanford, MIT), indicating deployment beyond internal demos, though no reviewed source documents a specific production-line integration case study with measured before/after results, and no field reliability data (MTBF, defect rate, return rate) exists for any model in production use. No formal customer support SLA or warranty terms were found beyond a general FAQ page on the company's JavaScript-rendered website. On roadmap, Linkerbot reveals milestones through trade-show events rather than a published release calendar: the CES 2026 debut introduced the full Linker Hand line plus the 'Linker Craftsman' workstation spanning 11 to 42 DoF, but no forward-looking roadmap (named next-generation models, target dates) was found beyond that reveal.[CE011, CE012, CE013, CE014, CE015, CE023]

5.4 Differentiation, trust, and compliance

Linkerbot's stated technology differentiation rests on three pillars: covering all three major actuation approaches in one product family (versus rivals that typically specialize in one), proprietary materials and manufacturing (PEEK polymer, in-house micro-reducers), and a claimed 80%+ market-share position built on cost/scale leadership rather than a single patentable breakthrough — no reviewed source discloses any patent portfolio, filing, or granted IP protection specific to Linkerbot's methods, and no source discloses manufacturing facility count or component-supplier detail. On trust and compliance, the picture is thin: no formal safety or quality certification (e.g., against ISO 10218 or ISO/TS 15066) is disclosed as held by Linkerbot specifically, though the company's ROS SDK README does include informal, developer-facing safety notes for hardware operation. No data-privacy or security policy was found for manipulation-skill or teleoperation data collected via LinkerSkillNet or Open TeleDex, and no manufacturing quality-control process (incoming/in-line/outgoing QA) is disclosed. China's National Development and Reform Commission's 2026 warning about excessive product duplication among more than 150 domestic humanoid-robot companies is a relevant sector-level adverse signal for whether rapid SKU proliferation across this whole industry — Linkerbot's 13+ SKUs included — has been matched by proportional quality and safety investment. Overall, the gap between demonstrably active open-source developer tooling and a near-total absence of disclosed certifications, IP, or reliability data suggests Linkerbot's public disclosure strategy currently favors developer adoption and press visibility over formal enterprise-trust documentation.[CE016, CE017, CE018, CE019, CE020, CE021]

5.5 Exhibits

6.1 Customer base segmentation

Linkerbot's disclosed customer base segments into at least three groups. Industrial and electronics-manufacturing customers — named across multiple sources as Samsung Electronics and Siemens — represent the segment where buyer, user, and payer are typically the same corporate procurement/automation function. Research institutions — Stanford, MIT, and Cambridge per company press materials, plus the University of Hong Kong per independent press coverage — represent a segment funded through grants and lab budgets rather than direct commercial procurement, valuable for reputational and pipeline reasons more than direct revenue. Humanoid-robot integrators are an implied third buyer class (since Linkerbot's hands are designed to be mounted on robot platforms), but no reviewed source names a specific integrator as a direct Linkerbot customer. No source discloses geographic distribution beyond these named accounts, company size/revenue-band segmentation, or a full customer-count breakdown by segment, leaving segmentation analysis anchored to a small number of named logos rather than a complete account map.[CU001, CU002, CU003, CU004]

6.2 Adoption trajectory

Linkerbot's adoption trajectory is documented almost entirely through unit-shipment and production-scale disclosures rather than account-level metrics. Monthly order volume was reported surpassing 1,000 units by November 2025, cumulative shipments exceeded 10,000 units by December 2025, and by May 2026 the company described scaling monthly production from almost 5,000 toward a 10,000-unit target. A separate Chinese-language report states the company targeted delivering 50,000 to 100,000 units across all of 2026 — a target substantially above its disclosed end-2025 cumulative level, though no source confirms a mid-year run-rate against that target. Beyond unit counts, Linkerbot also won the championship title at the 9th Zhongguancun International Advanced Technology Competition (announced March 26, 2026) among more than 2,100 participating global projects, a form of third-party technical validation distinct from a direct sales or usage metric. No reviewed source converts any of this shipment activity into a distinct-customer-account count, deployment-location count, or utilization rate, so adoption trajectory remains a production-scale story rather than a customer-account story.[CU005, CU006, CU007, CU008]

6.3 Named customer proof: production vs. pilot and evidence freshness

Six named customers/institutions were found across reviewed sources: Samsung Electronics and Siemens on the industrial side, and Stanford, MIT, Cambridge, and the University of Hong Kong on the research side. Samsung Electronics has the strongest evidentiary basis, named consistently across three independent-ish sources (China Biz Insider, PR Newswire, and Interesting Engineering); Siemens and Stanford each have two-source corroboration; MIT and Cambridge appear only in Linkerbot's own press release without independent confirmation in the sources reviewed; and the University of Hong Kong appears only in a single independent press source not mentioned in Linkerbot's own reviewed materials. Critically, no source for any of the six specifies whether the relationship reflects a production deployment, a pilot, or a one-time demonstration/loan of equipment, and no source provides any quantified outcome metric (cycle-time improvement, defect-rate change, cost savings) for any account — all customer proof found here is logo-level rather than outcome-level. All of this evidence is dated between November 2025 and May 2026, meeting the freshness bar for a mid-2026 report, though no source explicitly reconfirms these relationships are still active as of the report date.[CU009, CU010, CU011, CU012, CU013, CU014]

6.4 Retention, durability, expansion, and concentration risk

On retention and durability, the public record is empty: no reviewed source discloses net or gross revenue retention, churn, renewal rate, contract length, or any customer-satisfaction metric for Linkerbot, and no source documents repeat-purchase behavior for any specific named account, so the rising order-volume trend cannot be attributed to new-customer growth, repeat/expansion orders, or some mix of both. On expansion and concentration, no source discloses a top-customer or top-5-customer revenue share, nor a total distinct customer/logo count, making it impossible to assess concentration risk as a share of the total account base rather than only in absolute, named terms. Channel/partner dependence appears limited based on Linkerbot's disclosed direct-sales and trade-show go-to-market motion, though two international B2B trade-directory listings — an HKTDC supplier storefront and a Hannover Messe exhibitor page — both returned not-found results as of the report date, a minor procurement-friction signal for prospective international buyers who might discover Linkerbot through those channels. At the sector level, China's National Development and Reform Commission's 2026 warning about more than 150 domestic humanoid-robot companies is a relevant adverse signal: an increasingly crowded competitive field could create customer-switching pressure that Linkerbot's currently thin retention and concentration disclosure gives no way to evaluate. Overall, the customer-evidence profile combines credible, multiply-corroborated named-customer logos with a near-total absence of retention, concentration, satisfaction, and outcome-level evidence — a pattern more consistent with an early-scaling hardware company than a mature enterprise vendor.[CU016, CU017, CU018, CU019, CU020, CU021]

6.5 Exhibits

7.1 Severity-ranked risk overview

Across regulatory, operational, partner, and people dimensions, the highest-severity risks for Linkerbot are: manufacturing scale-up shortfall against a disclosed 10,000-unit/month (and separately reported 50,000-100,000-unit full-year 2026) target with no disclosed capex plan; US federal procurement bans (the GUARD Act and American Security Robotics Act) that could close off US-linked demand for Chinese-made robotics components; key-person and succession risk concentrated in a single publicly named executive; and capital-provider concentration among a small number of large, partly state-linked institutional investors. Each of these carries a plausible investment implication — from reduced near-term revenue growth (manufacturing shortfall), to a shrinking addressable market in the US (regulatory), to abrupt leadership discontinuity (people risk), to financing fragility if investor sentiment shifts (capital concentration). Mitigation maturity is uniformly low: no reviewed source documents a specific contingency plan, insurance policy, or risk-management disclosure from Linkerbot for any of these top risks, which is itself a notable gap for a company operating at a multi-billion-dollar valuation.[CR001, CR016, CR020, CR025, CR034, CR041]

7.2 Regulatory and legal risk

Linkerbot faces regulatory risk on both the US and Chinese sides of the market. In the US, lawmakers introduced the bipartisan GUARD Act and American Security Robotics Act in March 2026, aimed at banning federal government procurement and use of Chinese-made humanoid and ground robots; no reviewed source confirms whether this scope would extend to components like dexterous hands embedded inside non-Chinese-branded robots, leaving the practical reach of this risk to Linkerbot uncertain but plausible. Separately, BIS's 2026 case-by-case AI-chip license-review process and the broader January 2025 export controls on advanced computing items and AI model weights add compliance obligations relevant to any embodied-AI hardware and software maker sourcing or exporting advanced compute. A law-firm analysis frames humanoid robots generally as entering 'a new era of risk' under existing product-liability and safety law, though no reviewed source documents any litigation, enforcement action, or IP dispute specific to Linkerbot. On the China side, a national humanoid-robot standards-setting technical committee is being formed with Unitree and AgiBot executives as members, but no reviewed source confirms Linkerbot has committee representation, raising a risk that binding technical standards could be shaped without its direct input; separately, China's NDRC publicly warned in 2026 of overcapacity and speculative bubbles among more than 150 domestic humanoid-robot companies, a sector-wide signal of possible future policy tightening. No source confirms whether Linkerbot holds ISO 10218 or ISO/TS 15066 safety certification, and the EU's AI Act adds a further, currently unconfirmed, compliance layer for any European sales.[CR001, CR002, CR003, CR004, CR005, CR006]

7.3 Operational, quality, and partner/dependency risk

On operational risk, the most material gap is between Linkerbot's disclosed production-scale ambitions — from roughly 5,000 to a targeted 10,000 units per month, and separately a reported 50,000-100,000-unit full-year 2026 delivery target — and a complete absence of disclosed manufacturing capacity, capex, or capital-expenditure plan to support that scale-up. No field reliability data (defect rate, MTBF), recall history, or cybersecurity practice is disclosed for any product, and the company's software stack carries a specific OS/framework dependency (Ubuntu 22.04, ROS Humble) that is an operational risk if that combination lags newer tooling. An industry tracker frames the category as moving toward commoditization as standalone-hand entrants (AgiBot, Zhaowei) compete on price, a margin-compression risk for Linkerbot's cost/scale-based moat, compounded by a credibility risk illustrated by a public Unitree-AgiBot dispute over shipment-leadership claims that applies equally to Linkerbot's own unaudited 80%+ share claim. On partner and dependency risk, Linkerbot's capital base is concentrated among a small number of large, partly state-linked institutional investors (Ant Group, HongShan Group, Zhongguancun Science Park Fund, Bank of China Asset Management, Fosun Capital), plus a single disclosed public-market strategic holder (Dongfang Precision, ~4.36%); any shift in investor sentiment among this small group could materially affect future financing. Customer concentration cannot be quantified because total customer count is undisclosed, though only a handful of named accounts have been publicly identified. Two international trade-directory listings (HKTDC, Hannover Messe) are currently not-found, a minor channel-dependency gap, and the broader semiconductor supply chain is exposed to escalating US export-control policy.[CR013, CR014, CR015, CR016, CR017, CR018]

7.4 People/execution and financial/model risk, mitigation, and kill criteria

People and execution risk center on a single publicly named executive: 2026 wire coverage names 'CEO Alex Zhou' while 2025 coverage names 'Founder and CTO Zhou Yong,' and a later independent source ties both names to one individual ('Alex Zhou Yong'), but no board, deputy, or succession plan is disclosed — a material governance gap at a multi-billion-dollar valuation. A reported plan to double the research team by the end of 2026, alongside aggressive production-volume growth targets, creates execution risk if hiring and quality-control capacity do not scale proportionally, though no current headcount baseline is disclosed to benchmark against. On financial/model risk, no source discloses cash on hand, burn rate, or runway, and the roughly RMB 1.5 billion February 2026 Series B round is not reconciled with the roughly $3 billion May 2026 'Series B+' valuation, leaving dilution and capital-efficiency risk unclear; no source confirms whether current pricing (e.g., the ~$920 O6 model) is consistent with a sustainable gross margin. Monitorable kill criteria/thesis-break triggers include: enacted US procurement-ban scope explicitly covering embedded components; any confirmed product recall or safety incident; a down round, valuation markdown, or confirmed miss versus the 2026 production target; departure of the sole named executive without a successor; and any independent audit materially contradicting Linkerbot's 80%+ market-share claim. Overall, this chapter's risk profile combines well-corroborated, sector-wide regulatory and overcapacity risk with a near-total absence of company-specific mitigation, certification, insurance, or contingency disclosure.[CR025, CR026, CR027, CR028, CR029, CR030]

7.5 Exhibits

8.1 Investment thesis and anti-thesis

The investment thesis for Linkerbot rests on disclosed 80%+ share in a fast-growing, cost-collapsing high-degree-of-freedom dexterous-hand category, corroborated unit-shipment growth (10,000+ cumulative units by December 2025, targeting 10,000 units per month and separately a reported 50,000-100,000-unit full-year 2026 delivery goal), and backing from major institutional investors — Ant Group, HongShan Group, Zhongguancun Science Park Fund, Bank of China Asset Management, and Fosun Capital — at a disclosed ~$3 billion valuation. A March 2026 technology-competition win and Beijing municipal-government recognition add qualitative credibility beyond the company's own statements. The anti-thesis is equally concrete: the market-share and shipment claims are self-defined and unaudited, and a public dispute between Unitree and AgiBot over shipment leadership shows this is a live, sector-wide credibility issue rather than a hypothetical concern; no revenue, gross margin, cash position, or headcount has been disclosed; the named customer base rests on a handful of logo-level accounts with no production-vs-pilot confirmation or outcome data; and China's own National Development and Reform Commission has publicly warned of overcapacity and speculative-bubble risk among more than 150 domestic humanoid-robot companies. On balance, the evidence base currently supports a growth narrative more than a due-diligence-grade financial or commercial case.[CV001, CV002, CV003, CV037]

8.2 Recommendation, confidence, and current financing context

Given the strength of the growth narrative but the near-total absence of audited financial or independently verified evidence, a 'research-more' recommendation with medium confidence, a high risk rating, and a 'stretched' valuation stance is more defensible than an outright buy or avoid call; no source supports a specific target return, hold period, or exit multiple, since no entry price, share class, or liquidation-preference terms are disclosed for any specific investor. On current financing context, Linkerbot closed a 'Series B+' round around late April/early May 2026 at approximately a $3 billion valuation and disclosed a roughly $6 billion target for its next round, without disclosing timing or instrument. A February 2026 Series B round of roughly RMB 1.5 billion (about $210 million) is not reconciled in any reviewed source with that $3 billion figure reached about three months later, making entry-price discipline difficult to assess independently for that window. The most concrete quasi-independent evidence bearing on the actual cap table is listed company Dongfang Precision's disclosed ~4.36% direct equity stake, confirmed through its own investor-relations disclosure — a genuinely useful anchor, but one data point far short of full cap-table visibility. Overall, public evidence is directionally consistent with continued investor demand but does not independently confirm that the disclosed $3 billion or targeted $6 billion figures represent fair value rather than momentum-driven pricing.[CV004, CV005, CV006, CV007, CV008, CV009]

8.3 Bull/base/bear scenarios and the comparable set

In a bull case, Linkerbot sustains its 80%+ share claim, hits its 50,000-100,000-unit 2026 delivery target, and raises its next round at or above the disclosed $6 billion target, aided by continued Chinese industrial-policy tailwinds. In a base case, growth continues but more moderately than stated, the next round closes below $6 billion, and price competition from AgiBot, Zhaowei, and other standalone-hand entrants intensifies. In a bear case, an independent audit or competitor dispute undermines the share claim, NDRC warnings translate into concrete policy tightening, and manufacturing scale-up falls short, forcing a down round or delayed fundraising; no source provides an explicit probability weighting across these scenarios, so this framing is qualitative and evidence-anchored rather than modeled. Against a comparable set spanning Unitree (~$1.6B, now IPO-filed with full prospectus-level disclosure), AgiBot (reportedly >RMB 7B, roughly $1B, the closest direct product-category comparable), Figure AI ($39B, the upper-bound Western comparable), Apptronik ($5B), and X Square Robot (>$2.8B), Linkerbot's disclosed ~$3 billion valuation sits well above its closest direct hand-product comparable but below the largest full-stack Western humanoid makers — suggesting the market is pricing Linkerbot closer to a broad humanoid-robotics platform than to a narrower hand-component supplier. No source discloses a revenue or EBITDA multiple for Linkerbot or any comparable, so this benchmarking rests on absolute round valuations rather than a standardized multiple, and whole-market analyst estimates (MarketsandMarkets, Goldman Sachs Research) provide macro tailwind context without directly pricing Linkerbot itself.[CV011, CV012, CV013, CV014, CV015, CV016]

8.4 Exit readiness, thesis-break triggers, and final diligence asks

No reviewed source discloses any exit event specific to Linkerbot; the closest evidence of exit readiness in the sector is comparable peer Unitree's own STAR Market IPO filing, which demonstrates a viable exit path exists generally, and given Linkerbot's disclosed scale and institutional-investor base, an eventual IPO — plausibly on a Chinese exchange — is a plausible but currently unconfirmed path; no source discloses lock-up terms or any secondary-sale mechanism for existing shareholders. Adverse signals relevant to valuation risk include China's NDRC 2026 warning about sector-wide overcapacity, the public Unitree-AgiBot dispute over shipment-leadership claims (a direct analogue to Linkerbot's own unaudited 80%+ share claim), and US legislative moves (the GUARD Act, American Security Robotics Act) that could constrain Linkerbot's addressable Western market. Four concrete, monitorable thesis-break triggers follow directly from the Risks chapter: an independent audit materially contradicting the market-share claim; a down round, delayed fundraising, or missed production target; enacted US legislation explicitly covering embedded components; and departure of the company's sole named executive without a disclosed successor. The single highest-value final diligence ask is an independent audit of Linkerbot's claimed market share and shipment volumes, since nearly every other valuation input is downstream of that claim's credibility; close behind are basic financial-statement access, reconciliation of the two 2026 funding events, and governance/key-person documentation.[CV022, CV023, CV024, CV025, CV026, CV027]

8.5 Exhibits